|
|
|
|
||
Re: "Gilvaari is the first RNAi drug to utilize GalNAc-conjugation to earn marketing approval. What does that mean?" If Motley Fool says it, the news is so worn and hackneyed, and their take on it so simplified and misunderstood, that its value to investors is akin to an empty toilet-paper roll in a public restroom. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
34751 | Re: "Gilvaari is the first RNAi drug to utilize GalNAc-conjugation to earn marketing approval. What does that mean?" | biochemyst | 0 | 12/12/2019 10:45:54 PM |